COX-2 gene promoter polymorphism and coronary artery disease in middle-aged men: The Helsinki sudden death study

Mediators of Inflammation

Volumn 2008, Issue , 2008, Pages

  Huuskonen, Kati H ^a   Kunnas, Tarja A ^a   Tanner, Minna M ^b   Mikkelsson, Jussi ^a,c   Ilveskoski, Erkki ^a,c   Karhunen, Pekka J ^a   Nikkari, Seppo T ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ENDONUCLEASE; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; AUTOPSY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; ENZYMOLOGY; FINLAND; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; AGED; CORONARY ARTERY DISEASE; CYCLOOXYGENASE 2; DEATH, SUDDEN; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 43849109019     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2008/289453     Document Type: Article

References (19)

1. DeWitt D., Smith W. L., Yes, but do they still get headaches? Cell 1995 83 3 345 348
2. Chandrasekharan N. V., Dai H., Roos K. L. T., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13926 13931
3. Baker C. S. R., Hall R. J. C., Evans T. J., Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 3 646 655
4. Schonbeck U., Sukhova G. K., Graber P., Coulter S., Libby P., Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions American Journal of Pathology 1999 155 4 1281 1291
5. Granstrom E., Diczfalusy U., Hamberg M., Hansson G., Malmsten C., Samuelsson B., Thromboxane a2: biosynthesis and effects on platelets Advances in Prostaglandin, Thromboxane, and Leukotriene Research 1982 10 15 58
6. Needleman P., Turk J., Jakschik B. A., Morrison A. R., Lefkowith J. B., Arachidonic acid metabolism Annual Review of Biochemistry 1986 55 69 102
7. Linton M. F., Fazio S., Cyclooxygenase-2 and inflammation in atherosclerosis. Current Opinion in Pharmacology 2004 4 2 116 123
8. Bunting S., Gryglewski R., Moncada S., Vane J. R., Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation Prostaglandins 1976 12 6 897 913
9. Papafili A., Hill M. R., Brull D. J., Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 10 1631 1636
10. Cipollone F., Toniato E., Martinotti S., A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke The Journal of the American Medical Association 2004 291 18 2221 2228
11. Colaizzo D., Fofi L., Tiscia G., The COX-2 G/C-765 polymorphism may modulate the occurrence of cerebrovascular ischemia Blood Coagulation and Fibrinolysis 2006 17 2 93 96
12. Orbe J., Beloqui O., Rodriguez J. A., Belzunce M. S., Roncal C., Páramo J. A., Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors Clinica Chimica Acta 2006 368 1-2 138 143
13. Hegener H. H., Diehl K. A., Kurth T., Gaziano J. M., Ridker P. M., Zee R. Y. L., Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach Journal of Thrombosis and Haemostasis 2006 4 8 1718 1722
14. Kohsaka S., Volcik K. A., Folsom A. R., Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the atherosclerosis risk in communities study Atherosclerosis 2008 196 2 926 930
15. Ilveskoski E., Perola M., Lehtimäki T., Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study Circulation 1999 100 6 608 613
16. Weman S. M., Salminen U. S., Penttilä A., Männikkö A., Karhunen P. J., Post-mortem cast angiography in the diagnostics of graft complications in patients with fatal outcome following coronary artery bypass grafting (CABG) International Journal of Legal Medicine 1999 112 2 107 114
17. Libby P., Geng Y. J., Aikawa M., Macrophages and atherosclerotic plaque stability Current Opinion in Lipidology 1996 7 5 330 335
18. Libby P., Molecular bases of the acute coronary syndromes Circulation 1995 91 11 2844 2850
19. Shah P. K., Falk E., Badimon J. J., Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture Circulation 1995 92 6 1565 1569